S. Gilpin

发表

Regeneration and Experimental Orthotopic Transplantation of a Bioengineered Kidney

J. Guyette, H. Ott, J. Vacanti, 2013, Nature Medicine.

Technological advances in study of lung regenerative medicine: perspective from the 2019 Vermont lung stem cell conference.

S. Gilpin, D. Weiss, D. Wagner, 2020, Cytotherapy.

Cell-specific gene expression in patients with usual interstitial pneumonia.

S. Gilpin, E. Cheng, J. Gauldie, 2006, American journal of respiratory and critical care medicine.

The transforming growth factor-beta (TGF-) family and pulmonary fibrosis

S. Gilpin, M. Kolb, J. Gauldie, 2006 .

Orthotopic Transplantation of Human Bioartificial Lung Grafts in a Porcine Model: A Feasibility Study.

H. Ott, S. Gilpin, K. Economopoulos, 2021, Seminars in thoracic and cardiovascular surgery.

Regenerative Medicine of the Respiratory Tract

P. Moser, H. Ott, S. Gilpin, 2019, Principles of Regenerative Medicine.

Acellular human lung scaffolds to model lung disease and tissue regeneration

S. Gilpin, D. Wagner, 2018, European Respiratory Review.

Bioengineering Human Lung Grafts on Porcine Matrix

X. Ren, H. Ott, D. Mathisen, 2018, Annals of surgery.

Regenerative potential of human airway stem cells in lung epithelial engineering.

X. Ren, H. Ott, D. Mathisen, 2016, Biomaterials.

Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung Cancer.

X. Ren, H. Ott, S. Gilpin, 2015, The Annals of thoracic surgery.

Using nature's platform to engineer bio-artificial lungs.

H. Ott, S. Gilpin, 2015, Annals of the American Thoracic Society.

Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis.

P. O'Byrne, R. Strieter, S. Gilpin, 2009, American journal of respiratory and critical care medicine.

Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal Scaffolds.

Bernhard J. Jank, P. Moser, X. Ren, 2020, Tissue engineering. Part A.

Protective effects of extracellular matrix derived hydrogels in idiopathic pulmonary fibrosis.

S. Gilpin, M. Miglino, D. Evangelista-Leite, 2021, Tissue engineering. Part B, Reviews.

An Of ﬁ cial American Thoracic Society Workshop Report 2015 Stem Cells and Cell Therapies in Lung Biology and Diseases Stem Cells and Cell Therapies

H. Ott, S. Randell, S. Gilpin, 2016 .

Proteomic analysis of naturally-sourced biological scaffolds.

Brian L. Frey, Lloyd M. Smith, H. Ott, 2016, Biomaterials.

AAV-mediated gene therapy targeting TRPV4 mechanotransduction for inhibition of pulmonary vascular leakage

D. Ingber, Maximilian A Benz, B. Matthews, 2019, APL bioengineering.

Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics

Donald E. Ingber, Rachelle Prantil-Baun, D. Ingber, 2020 .

Mechanical control of innate immune responses against viral infection revealed in a human lung alveolus chip

Rani K. Powers, D. Ingber, R. Powers, 2021, Nature Communications.

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

Rani K. Powers, D. Ingber, S. Gygi, 2021, Nature Biomedical Engineering.

Bioengineering of functional human induced pluripotent stem cell-derived intestinal grafts

X. Ren, H. Ott, G. Wojtkiewicz, 2017, Nature Communications.

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019

S. Gilpin, B. Davis, C. M. Magin, 2020, ERJ Open Research.

Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale.

Xi Ren, Joseph P Vacanti, John M Asara, 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bioengineering Lungs for Transplantation.

X. Ren, H. Ott, S. Gilpin, 2016, Thoracic surgery clinics.

THE SCAFFOLD : DECELLULARIZED NATIVE EXTRACELLULAR MATRIX

X. Ren, H. Ott, S. Gilpin, 2022 .

Enhanced lung epithelial specification of human induced pluripotent stem cells on decellularized lung matrix.

Xi Ren, Hongmei Mou, Joseph P Vacanti, 2014, The Annals of thoracic surgery.

Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration.

Brian L. Frey, X. Ren, H. Ott, 2017, Biomaterials.

Human Lung Progenitor Populations in End-stage Lung Disease and Transplantation.

S. Gilpin, 2012 .

Modeling Pulmonary Cystic Fibrosis in a Human Lung Airway-on-a-chip

D. Ingber, S. Gilpin, M. Romano, 2021, medRxiv.

Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics

Kohei Oishi, Donald E. Ingber, Rani K. Powers, 2020, bioRxiv.

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report

Deniz A. Bölükbas, S. Gilpin, S. Atarod, 2019, American journal of respiratory cell and molecular biology.

Altered progenitor cell and cytokine profiles in bronchiolitis obliterans syndrome.

S. Gilpin, S. Keshavjee, T. Waddell, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip: Cystic fibrosis airway chip.

D. Ingber, S. Gilpin, M. Romano, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Bioengineering Human Myocardium on Native Extracellular Matrix.

Robert W. Mills, Joshua R Gershlak, Harald C Ott, 2016, Circulation research.

Design and validation of a clinical-scale bioreactor for long-term isolated lung culture

Atsushi Yasuda, Douglas J. Mathisen, Harald C. Ott, 2015, Biomaterials.

Perfusion decellularization of whole organs

Xi Ren, Harald C Ott, J. Guyette, 2014, Nature Protocols.

Mucus production, host-microbiome interactions, hormone sensitivity, and innate immune responses modeled in human endo- and ecto-cervix chips

D. Ingber, C. Lebrilla, S. Gilpin, 2023 .

172: CCSP+ Progenitor Cells Respond to Lung Injury and Transplantation

S. Gilpin, S. Keshavjee, T. Waddell, 2010 .

A Fully Automated High-Throughput Bioreactor System for Lung Regeneration.

Tong Wu, Harald C Ott, H. Ott, 2018, Tissue engineering. Part C, Methods.

Engineering pulmonary vasculature in decellularized rat and human lungs

Xi Ren, Tong Wu, Harald C Ott, 2015, Nature Biotechnology.

Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs

H. Ott, M. Mino‐Kenudson, S. Gilpin, 2022, Biomaterials.

Bone marrow-derived progenitor cells in end-stage lung disease patients

S. Gilpin, S. Keshavjee, T. Waddell, 2013, BMC Pulmonary Medicine.

Metabolic glycan labeling and chemoselective functionalization of native biomaterials.

X. Ren, H. Ott, D. Mathisen, 2018, Biomaterials.

Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases 2017. An Official American Thoracic Society Workshop Report

Deniz A. Bölükbas, S. Gilpin, S. Atarod, 2019, American journal of respiratory cell and molecular biology.

An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases.

H. Ott, S. Randell, S. Gilpin, 2016, Annals of the American Thoracic Society.

Up-Scaling Decellularization and Whole Organ Culture for Human Lung Regeneration

L. Xiong, J. Guyette, X. Ren, 2013 .

Fibrillin-2 and Tenascin-C bridge the age gap in lung epithelial regeneration.

Brian L. Frey, X. Ren, H. Ott, 2017, Biomaterials.

Design and validation of a clinical-scale bioreactor for long-term isolated lung culture

H. Ott, D. Mathisen, S. Gilpin, 2015, Biomaterials.